BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31786309)

  • 41. Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1.
    Sun EC; Zhao J; Liu NH; Yang T; Ma JN; Geng HW; Wang LF; Qin YL; Bu ZG; Yang YH; Lunt RA; Wang LF; Wu DL
    J Gen Virol; 2012 Jan; 93(Pt 1):50-60. PubMed ID: 21940411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Japanese Encephalitis Virus Induces Apoptosis and Encephalitis by Activating the PERK Pathway.
    Wang Q; Xin X; Wang T; Wan J; Ou Y; Yang Z; Yu Q; Zhu L; Guo Y; Wu Y; Ding Z; Zhang Y; Pan Z; Tang Y; Li S; Kong L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteomic analyses identify intracellular targets for Japanese encephalitis virus nonstructural protein 1 (NS1).
    Wang P; Liu X; Li Q; Wang J; Ruan W
    Virus Res; 2021 Sep; 302():198495. PubMed ID: 34175344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Japanese encephalitis virus NS1 protein expression in cell by small interfering RNAs.
    Liu X; Cao S; Zhou R; Xu G; Xiao S; Yang Y; Sun M; Li Y; Chen H
    Virus Genes; 2006 Aug; 33(1):69-75. PubMed ID: 16791421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain.
    Kumar P; Krishna VD; Sulochana P; Nirmala G; Haridattatreya M; Satchidanandam V
    J Gen Virol; 2004 Feb; 85(Pt 2):471-482. PubMed ID: 14769905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunogenicity and antigenicity of Japanese encephalitis virus envelope protein domain III].
    Huang Y; Liu S; Yang P; Du Y; Sun Z; Yu W
    Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1532-7. PubMed ID: 20112698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C19orf66 Inhibits Japanese Encephalitis Virus Replication by Targeting -1 PRF and the NS3 Protein.
    Yu D; Zhao Y; Pan J; Yang X; Liang Z; Xie S; Cao R
    Virol Sin; 2021 Dec; 36(6):1443-1455. PubMed ID: 34309824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
    Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination.
    Gao N; Chen W; Zheng Q; Fan DY; Zhang JL; Chen H; Gao GF; Zhou DS; An J
    Immunol Lett; 2010 Mar; 129(1):23-31. PubMed ID: 20064558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation and characterization of Japanese encephalitis virus specific monoclonal antibodies.
    Ma SH; Lin YL; Huang YY; Liu CI; Chen SS; Chiang HY; Chen LK
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 May; 28(2):128-38. PubMed ID: 9774991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.
    Konishi E; Pincus S; Paoletti E; Laegreid WW; Shope RE; Mason PW
    Virology; 1992 Sep; 190(1):454-8. PubMed ID: 1326813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal Antibodies Against NS2B of Japanese Encephalitis Virus.
    Dong Q; Xu Q; Ruan X; Huang S; Cao S
    Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):96-100. PubMed ID: 25897607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Roles of N-glycosylation in immunity of prME and NS1 gene of JEV].
    Zhang ZZ; Wang X; Zai JJ; Sun LQ; Song YF; Chen HC
    Bing Du Xue Bao; 2012 May; 28(3):213-8. PubMed ID: 22764522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction of a Recombinant Japanese Encephalitis Virus with a Hemagglutinin-Tagged NS2A: A Model for an Analysis of Biological Characteristics and Functions of NS2A during Viral Infection.
    Ma X; Li C; Xia Q; Zhang Y; Yang Y; Wahaab A; Liu K; Li Z; Li B; Qiu Y; Wei J; Ma Z
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Japanese Encephalitis Virus (JEV) NS1' Enhances the Viral Infection of Dendritic Cells (DCs) and Macrophages in Pig Tonsils.
    Xie S; Pan J; Zhang Q; Guan R; Yang X; Yang X; Liang Z; Cao R
    Microbiol Spectr; 2022 Aug; 10(4):e0114722. PubMed ID: 35730942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
    Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
    Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.